53
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia

, , &
Pages 485-500 | Published online: 04 Feb 2016

References

  • HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667410.1016/j.cell.2011.02.01321376230
  • Von der MaaseHHansenSWRobertsJTGemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyJ Clin Oncol200018173068307711001674
  • TietzeRLyerSDürrSEfficient drug-delivery using magnetic nanoparticles – biodistribution and therapeutic effects in tumour bearing rabbitsNanomedicine20139796197110.1016/j.nano.2013.05.00123669367
  • JankoCDürrSMunozLEMagnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytesInt J Mol Sci20131447341735510.3390/ijms1404734123549268
  • Fortin-RipocheJ-PMartinaMSGazeauFMagnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibilityRadiology2006239241542410.1148/radiol.239204211016549622
  • YangYJiangJ-SDuBGanZ-FQianMZhangPPreparation and properties of a novel drug delivery system with both magnetic and biomolecular targetingJ Mater Sci Mater Med200920130130710.1007/s10856-008-3577-018791664
  • HuangHSHainfieldJFIntravenous magnetic nanoparticle cancer hyperthermiaInt J Nanomedicine201382521253210.2147/IJN.S4377023901270
  • StapfMPömpnerNKetteringMHilgerIMagnetic thermoablation stimuli alter BCL2 and FGF-R1 but not HSP70 expression profiles in BT474 breast tumorsInt J Nanomedicine201510101931193910.2147/IJN.S7737225792827
  • KossatzSLudwigRDähringHHigh therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor areaPharm Res201431123274328810.1007/s11095-014-1417-024890197
  • LudwigRStapfMDutzSMüllerRTeichgräberUHilgerIStructural properties of magnetic nanoparticles determine their heating behavior – an estimation of the in vivo heating potentialNanoscale Res Lett20149160210.1186/1556-276X-9-60225404872
  • ZalogaJStapfMNowakJTangential flow ultrafiltration allows purification and concentration of lauric acid-/albumin-coated particles for improved magnetic treatmentInt J Mol Sci2015168192911930710.3390/ijms16081929126287178
  • FriedrichRPJankoCPoettlerMFlow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methodsInt J Nanomedicine2015104185420110.2147/IJN.S8271426170658
  • WeisslederRBogdanovANeuweltEAPapisovMLong-circulating iron oxides for MR imagingAdv Drug Deliv Rev1995162–332133410.1016/0169-409X(95)00033-4
  • OkonEPouliquenDOkonPBiodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical studyLab Invest19947168959037807971
  • LãbbeASBergemannCHuhntWFrickeTRiessHPredinical experiences drug targeting: tolerance and efficacyStatistics (Ber)199646944701
  • HergtRDutzSMüllerRZeisbergerMMagnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapyJ Phys Condens Matter20061838S2919S293410.1088/0953-8984/18/38/S26
  • SpurlockCFTossbergJTFuchsHAOlsenNJAuneTMMethotrexate increases expression of cell cycle checkpoint genes via JNK activationArthritis Rheum20126461780178910.1002/art.3434222183962
  • GoncharovaSAFrankfurtOSEffect of methotrexate on the cell cycle of L1210 leukemiaCell Tissue Kinet197694333340945129
  • LimC-UZhangYFoxMHCell cycle dependent apoptosis and cell cycle blocks induced by hyperthermia in HL-60 cellsInt J Hyperthermia2006221779110.1080/0265673050043053816423754
  • CossRADeweyCBamburgJREffects of hyperthermia on dividing Chinese hamster Ovary cells and on microtubules in vitroCancer Res1982423105911077199378
  • BhuyanBKKinetics of cell kill by hyperthermiaCancer Res1979396 II22772284376117
  • ZwickeGMansooriGJefferyCUtilizing the folate receptor for active targeting of cancer nanotherapeuticsNano Rev20121111 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521101/Accessed September 26, 2014
  • ChanESLCronsteinBNMechanisms of action of methotrexateBull NYU Hosp Jt Dis201371suppl 15810.1016/S0162-3109(00)00189-2
  • CheokMHEvansWEAcute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapyNat Rev Cancer20066211712910.1038/nrc180016491071
  • GenestierLPaillotRQuemeneurLIzeradjeneKRevillardJ-PMechanisms of action of methotrexateImmunopharmacology2000472–324725710.1016/S0162-3109(00)00189-210878292
  • BrzezinskaAWinskaPBalinskaMCellular aspects of folate and antifolate membrane transportActa Biochim Pol2000473735749 http://www.ncbi.nlm.nih.gov/pubmed/1131097311310973
  • YooHSParkTGFolate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugateJ Control Release2004100224725610.1016/j.jconrel.2004.08.01715544872
  • ParkerNTurkMJWestrickELewisJDLowPSLeamonCPFolate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayAnal Biochem2005338228429310.1016/j.ab.2004.12.02615745749
  • WernerMEKarveSSukumarRFolate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasisBiomaterials201132338548855410.1016/j.biomaterials.2011.07.06721843904
  • SaulJMAnnapragadaANatarajanJVBellamkondaRVControlled targeting of liposomal doxorubicin via the folate receptor in vitroJ Control Release2003921–24967 http://www.ncbi.nlm.nih.gov/pubmed/1449918514499185
  • AliASGRezaMAEshghiHSazgarniaAMontazerabadiARCancerous cells targeting and destruction using folate conjugated gold nanoparticlesDyn Biochem Process Biotechnol Mol Biol20104612
  • DhawanDRamos-VaraJANaughtonJFTargeting folate receptors to treat invasive urinary bladder cancerCancer Res201373287588410.1158/0008-5472.CAN-12-210123204225
  • CampbellIGJonesTAFoulkesWDTrowsdaleJFolate binding protein is a marker for ovarian cancerCancer Res1991513353295338 http://www.biomednet.com/db/medline/920054541717147
  • MatherlyLHGoldmanDIMembrane transport of folatesVitam Horm20036640345612852262
  • MatherlyLHHouZDengYHuman reduced folate carrier: translation of basic biology to cancer etiology and therapyCancer Metastasis Rev20072611112810.1007/s10555-007-9046-217334909
  • MatherlyLHHouZChapter 5 structure and function of the reduced folate carrier. A paradigm of a major facilitator superfamily mammalian nutrient transporterVitam Horm2008790814518410.1016/S0083-6729(08)00405-618804694
  • WhetstineJRFlatleyRMMatherlyLHThe human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoterBiochem J200236762964010.1042/BJ2002051212144527
  • GongMCowanKHGudasJMoscowJAIsolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1)Gene19992331–2213110.1016/S0378-1119(99)00166-310375617
  • LiuMGeYCabelofDCStructure and regulation of the murine reduced folate carrier gene: identification of four noncoding exons and promoters and regulation by dietary folatesJ Biol Chem200528075588559710.1074/jbc.M41266220015579899
  • WangYZhaoRRussellRGGoldmanIDLocalization of the murine reduced folate carrier as assessed by immunohistochemical analysisBiochim Biophys Acta – Biomembr200115131495410.1016/S0005-2736(01)00340-6
  • SpinellaMJBrigleKESierraEEGoldmanIDDistinguishing between folate receptor-α-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cellsJ Biol Chem1995270147842784910.1074/jbc.270.14.78427713875
  • HooijbergJHBroxtermanHJKoolMAntifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2 advances in brief antifolate resistance mediated by the multidrug resistance proteins MRP1Cancer Res199959112532253510363967
  • KoolMvan der LindenMde HaasMMRP3, an organic anion transporter able to transport anti-cancer drugsProc Natl Acad Sci U S A199996June6914691910.1073/pnas.96.12.691410359813
  • AssarafYGGoldmanIDLoss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cellsJ Biol Chem199727228174601746610.1074/jbc.272.28.174609211890
  • StarkMRothemLJansenGSchefferGLGoldmanIDAssarafYGAntifolate resistance associated with loss of MRP1 expression and function in Chinese hamster ovary cells with markedly impaired export of folate and cholateMol Pharmacol200364222022710.1124/mol.64.2.22012869626
  • AssarafYGRothemLHooijbergJHLoss of multidrug resistance protein 1 expression and folate efflux activity results in a highly concentrative folate transport in human leukemia cellsJ Biol Chem200327896680668610.1074/jbc.M20918620012486126
  • IferganIShafranAJansenGHooijbergJHSchefferGLAssarafYGFolate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression: a role for BCRP in cellular folate homeostasisJ Biol Chem200427924255272553410.1074/jbc.M40172520015047700
  • WielingaPHooijbergJHGunnarsdottirSThe human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolatesCancer Res200565104425443010.1158/0008-5472.CAN-04-281015899835
  • MindellJALysosomal acidification mechanismsAnnu Rev Physiol2012741698610.1146/annurev-physiol-012110-14231722335796
  • SpencerJPEWongJJennerAAruomaOICrossCEHalliwellBBase modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3-morpholinosydnonimineChem Res Toxicol1996971152115810.1021/tx960084i8902271
  • TowbinHStaehelinTGordonJElectrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applicationsProc Natl Acad Sci U S A19797694350435410.1073/pnas.76.9.4350388439
  • SaparetoSADeweyWCThermal dose determination in cancer therapyInt J Radiat Oncol Biol Phys198410678780010.1016/0360-3016(84)90379-16547421
  • JinHHellerDASharmaRStranoMSSize-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and nanoparticlesACS Nano20093114915819206261
  • ChithraniBDChanWCWElucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapesNano Lett2007761542155010.1021/nl070363y17465586
  • RobertsSJPetropavlovskajaMChungKNKnightCBElwoodPCRole of individual N-linked glycosylation sites in the function and intracellular transport of the human alpha folate receptorArch Biochem Biophys1998351222723510.1006/abbi.1997.05519515058
  • LiangX-JShenD-WGarfieldSGottesmanMMMislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell linesCancer Res200363185909591614522917
  • BerettaGLBenedettiVCossaGIncreased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatinBiochem Pharmacol20107981108111710.1016/j.bcp.2009.12.00220005867
  • HartmannLCKeeneyGLLingleWLFolate receptor overexpression is associated with poor outcome in breast cancerInt J Cancer2007121593894210.1002/ijc.2281117487842
  • JhaveriMSRaitASChungK-NTrepelJBChangEHAntisense oligonucleotides targeted to the human alpha folate receptor inhibit breast cancer cell growth and sensitize the cells to doxorubicin treatmentMol Cancer Ther20043121505151215634643
  • WormJKirkinAFDzhandzhugazyanKNGuldbergPMethylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cellsJ Biol Chem200127643399904000010.1074/jbc.M10318120011509559
  • YangRLiW-WHoangBHQuantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrierBMC Cancer2008812410.1186/1471-2407-8-12418452618
  • VolkELFarleyKMWuYLiFRobeyRWSchneiderEOverexpression of wild-type breast cancer resistance protein mediates methotrexate resistanceCancer Res200262175035504012208758
  • ChenZSRobeyRWBelinskyMGTransport of methotrexate, methotrexate polyglutamates, and 17β-estradiol 17-(β-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transportCancer Res200363144048405412874005
  • RheeMSSchneiderELack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell lineBiochem Pharmacol200569112313210.1016/j.bcp.2004.09.00715588721
  • RampersaudENVujaskovicZInmanBAHyperthermia as a treatment for bladder cancerOncology (Williston Park)201024121149115521141697
  • FrankeKKetteringMLangeKKaiserWAHilgerIThe exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levelsInt J Nanomedicine2013835136310.2147/IJN.S3746523378758
  • HermanTSCressAESweetsCGernerEWReversal of resistance to methotrexate by hyperthermia in Chinese hamster ovary cellsCancer Res19814110384038437284991
  • GossPParsonsPGThe effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell lines the effect of hyperthermia and melphalan on survival of human fibroblast strains and melanoma cell linesCancer Res1977371152156830403
  • Van der HeijdenAGVerhaeghGJansenCFJSchalkenJAWitjesJAEffect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro studyJ Urol200517341375138010.1097/01.ju.0000146274.85012.e115758808
  • HauckTSJenningsTLYatsenkoTKumaradasJCChanWCWEnhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermiaAdv Mater200820203832383810.1002/adma.200800921
  • MurrayTGCicciarelliNMcCabeCMIn vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell lineInvestig Ophthalmol Vis Sci19973812251625229375570
  • TeicherBAKowalCDKennedyKASartorelliACEnhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cellsCancer Res1981413109610997459853
  • WallnerKEBandaMLiGCHyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cellsCancer Res1987475130813123102043
  • WallnerKEDeGregorioMWLiGCHyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drugCancer Res19864612 I624262453779644
  • KetteringMRichterHWiekhorstFMinimal-invasive magnetic heating of tumors does not alter intra-tumoral nanoparticle accumulation, allowing for repeated therapy sessions: an in vivo study in miceNanotechnology2011225050510210.1088/0957-4484/22/50/50510222107782